C07C219/06

NEW QUATERNARY AMMONIUM COMPOUNDS
20220306570 · 2022-09-29 ·

The invention concerns new quaternary ammonium compounds with surfactant properties and improved biodegradability.

##STR00001##

NEW QUATERNARY AMMONIUM COMPOUNDS
20220306570 · 2022-09-29 ·

The invention concerns new quaternary ammonium compounds with surfactant properties and improved biodegradability.

##STR00001##

NON-IONIC AMPHIPHILES AND METHODS OF MAKING THE SAME
20170233337 · 2017-08-17 ·

Sugar-derived tetrol, non-ionic amphiphilic amine-esters are prepared facilely and efficaciously in a few steps. The process is initiated by the esterification of a sugar-derived tetrol with a fatty acid chloride, then, undergoing triflate esterification followed by nucleophilic displacement of the aforementioned hydrophilic amine. Each synthetic pathway is efficient and affords modest to high yields of target amphiphiles, which are valorized as practicable surfactant surrogates to petroleum incumbents.

NON-IONIC AMPHIPHILES AND METHODS OF MAKING THE SAME
20170233337 · 2017-08-17 ·

Sugar-derived tetrol, non-ionic amphiphilic amine-esters are prepared facilely and efficaciously in a few steps. The process is initiated by the esterification of a sugar-derived tetrol with a fatty acid chloride, then, undergoing triflate esterification followed by nucleophilic displacement of the aforementioned hydrophilic amine. Each synthetic pathway is efficient and affords modest to high yields of target amphiphiles, which are valorized as practicable surfactant surrogates to petroleum incumbents.

LIPIDS FOR DELIVERY OF CHARGED MATERIAL, FORMULATIONS THEREOF AND METHOD FOR MAKING SAME
20220304929 · 2022-09-29 ·

Disclosed herein is a lipid having a net charge at physiological pH, and being covalently attached to a lipid moiety. The lipid moiety comprises a hydrocarbon structure having two or more linked hydrocarbon chains, optionally having cis or trans C═C, at least one of said chains being covalently attached to the head group optionally via the linker region. The hydrocarbon chains are bonded to one another at a branch point at an internal carbon of the chain attached to the linker region, which branch point comprises a functional group having an electronegative atom. The hydrocarbon chains each have between 1 and 40 carbon atoms, wherein the hydrocarbon structure in total comprises between 10 and 150 carbon atoms. Advantageously, the hydrocarbon structure may assume a generally flared shape for enhanced delivery of cargo molecules. Further provided are delivery vehicles comprising the lipids.

LIPIDS FOR DELIVERY OF CHARGED MATERIAL, FORMULATIONS THEREOF AND METHOD FOR MAKING SAME
20220304929 · 2022-09-29 ·

Disclosed herein is a lipid having a net charge at physiological pH, and being covalently attached to a lipid moiety. The lipid moiety comprises a hydrocarbon structure having two or more linked hydrocarbon chains, optionally having cis or trans C═C, at least one of said chains being covalently attached to the head group optionally via the linker region. The hydrocarbon chains are bonded to one another at a branch point at an internal carbon of the chain attached to the linker region, which branch point comprises a functional group having an electronegative atom. The hydrocarbon chains each have between 1 and 40 carbon atoms, wherein the hydrocarbon structure in total comprises between 10 and 150 carbon atoms. Advantageously, the hydrocarbon structure may assume a generally flared shape for enhanced delivery of cargo molecules. Further provided are delivery vehicles comprising the lipids.

TRANSPARENT TEXTILE CARE AGENT

The present disclosure relates to textile care agents and to optically clear and transparent fabric softener formulations which also have a viscous consistency, containing a combination of special ester quats with nonionic emulsifiers and cationic thickeners, to the use of said textile care agents and fabric softener formulations. The present disclosure also relates to a method for washing textiles using said textile care agent and fabric softener formulations. The present disclosure relates to methods for producing the special ester quats, to the thus resulting ester quats and to the use thereof.

TRANSPARENT TEXTILE CARE AGENT

The present disclosure relates to textile care agents and to optically clear and transparent fabric softener formulations which also have a viscous consistency, containing a combination of special ester quats with nonionic emulsifiers and cationic thickeners, to the use of said textile care agents and fabric softener formulations. The present disclosure also relates to a method for washing textiles using said textile care agent and fabric softener formulations. The present disclosure relates to methods for producing the special ester quats, to the thus resulting ester quats and to the use thereof.

High penetration drugs and their compositions thereof for treatment of parkinson diseases
09718766 · 2017-08-01 · ·

One aspect of the invention provides a composition of novel high penetration compositions (HPC) or a high penetration prodrug (HPP) for treatment of Parkinson's disease. The HPCs/HPPs are capable of being converted to parent active drugs or drug metabolites after crossing the biological barrier and thus can render treatments for the conditions that the parent drugs or metabolites can. Additionally, the HPPs are capable of reaching areas that parent drugs may not be able to access or to render a sufficient concentration at the target areas and therefore render novel treatments. The HPCs/HPPs can be administered to a subject through various administration routes, e.g., locally delivered to an action site of a condition with a high concentration or systematically administered to a biological subject and enter the general circulation with a faster rate.

High penetration drugs and their compositions thereof for treatment of parkinson diseases
09718766 · 2017-08-01 · ·

One aspect of the invention provides a composition of novel high penetration compositions (HPC) or a high penetration prodrug (HPP) for treatment of Parkinson's disease. The HPCs/HPPs are capable of being converted to parent active drugs or drug metabolites after crossing the biological barrier and thus can render treatments for the conditions that the parent drugs or metabolites can. Additionally, the HPPs are capable of reaching areas that parent drugs may not be able to access or to render a sufficient concentration at the target areas and therefore render novel treatments. The HPCs/HPPs can be administered to a subject through various administration routes, e.g., locally delivered to an action site of a condition with a high concentration or systematically administered to a biological subject and enter the general circulation with a faster rate.